investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Structural and Functional Studies of Tumor Suppressor Proteins PALB2 and BRCA2
Sergey Korolev
1 Collaborator(s)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
The goal is to reveal mechanism of proteins function in DNA repair and cancer development.
Related projects
Sandra Mcallister
Understanding How Breast Cancers Activate and Respond to the Systemic Environment
Breast
Stuart Keith Calderwood
Extracellular Hsp70 and hyperthermia in tumor therapy
Breast
Maria Jasin
HOMOLOGY-DIRECTED DNA REPAIR PROTEINS BRCA2 AND RAD51 IN TUMOR RELEVANT TISSUES
Breast
Lisa M Coussens
Regulating the Immune Microenvironment in Breast Cancer
Breast
Dario Marchetti
Heparanase Mechanisms in Brain-metastatic Breast Cancer
Breast
Mark I Greene
Carbohydrate Antigenic Biomarkers for Epithelial Cancers
Breast
Dharmendra Dingar
In vivo BioID identifies novel c-MYC interacting partners
Breast
Dihua Yu
Enhancing Chemo-Response in Triple-Negative Breast Cancer by Activiating T-Cell Response
Breast
James K Turkson
Salicylic Acid-Based Small-Molecule Stat3 Inhibitors for Anticancer Therapy
Breast